Erika Borlenghi

23PUBLICATIONS
113CO-AUTHORS
NanomedicineHaematologyCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Nov 18, 2025
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex disease.

Diego Bertoli, Carlotta Giupponi, Giuseppe Rossi

|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

|Aug 21, 2025
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.

Roberto Cairoli, Lorenzo Del Castello, Silvia Imbergamo

|Aug 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Uwe Platzbecker, Lionel Adès, Pau Montesinos

|Mar 22, 2025
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.

Cristina Papayannidis, Elisabetta Petracci, Patrizia Zappasodi

Pageof 4

Frequent Collaborators

6 joint publications

Chiara Cattaneo

4 joint publications

Patrizia Zappasodi

4 joint publications

Calogero Vetro

3 joint publications

Massimo Bernardi